Your browser doesn't support javascript.
loading
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis.
Huang, Yao-Hui; Cai, Kun; Xu, Peng-Peng; Wang, Li; Huang, Chuan-Xin; Fang, Ying; Cheng, Shu; Sun, Xiao-Jian; Liu, Feng; Huang, Jin-Yan; Ji, Meng-Meng; Zhao, Wei-Li.
Affiliation
  • Huang YH; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cai K; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu PP; School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Wang L; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang CX; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Fang Y; Department of Immunobiology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cheng S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Sun XJ; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Liu F; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang JY; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ji MM; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. jimengmeng025@163.com.
Signal Transduct Target Ther ; 6(1): 10, 2021 01 11.
Article in En | MEDLINE | ID: mdl-33431788

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Lymphoma, Large B-Cell, Diffuse / Tumor-Associated Macrophages / Neoplasm Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Signal Transduct Target Ther Year: 2021 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Lymphoma, Large B-Cell, Diffuse / Tumor-Associated Macrophages / Neoplasm Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Signal Transduct Target Ther Year: 2021 Document type: Article Affiliation country: China